journal article·2024-05-01

Polyvalent Aptamer-Functionalized NIR-II Quantum Dots for Targeted Theranostics in High PD-L1-Expressing Tumors

Xin Huang, Jiawei Zhu, Chuhuang Dong, Yuqing Li, Qing Yu, Xuan Wang, Zhejie Chen, Jiabei Li, Yu Yang, Haifang Wang

ACS Applied Materials & Interfaces· Volume 16· Issue 17
Publisher page

Abstract

Ag 2 S quantum dots (QDs) show superior optical properties in the NIR-II region and display significant clinical potential with favorable biocompatibility. However, inherent defects of low targeting and poor solubility necessitate practical modification methods to achieve the theranostics of Ag 2 S QDs. Herein, we used rolling circle amplification (RCA) techniques to obtain long single-stranded DNA containing the PD-L1 aptamer and C-rich DNA palindromic sequence. The C-rich DNA palindromic sequences can specifically chelate Ag 2+ and thus serve as a template to result in biomimetic mineralization and formation of pApt-Ag 2 S QDs. These QDs enable specific targeting and illuminate hot tumors with high PD-L1 expression effectively, serving as excellent molecular targeted probes. In addition, due to the high NIR-II absorption of Ag 2 S QDs, pApt-Ag 2 S QDs exhibit remarkable photothermal properties. And besides, polyvalent PD-L1 aptamers can recognize PD-L1 protein and effectively block the inhibitory signal of PD-L1 on T cells, enabling efficient theranostics through the synergistic effect of photothermal therapy and immune checkpoint blocking therapy. Summary, we enhance the biological stability and antibleaching ability of Ag 2 S QDs using long single-stranded DNA as a template, thereby establishing a theranostic platform that specifically targets PD-L1 high-expressing inflamed tumors and demonstrates excellent performance both in vitro and in vivo .
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China

Institute of Molecular Medicine (IMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P. R. China

Funding

National Key Research and Development Program of China · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine

References (42)

Show source-provided references
1. 10.1021/acsnano.1c0913910.1021/acsnano.1c09139 ↗
2. 10.1039/D2CS00799A10.1039/D2CS00799A ↗
3. 10.1016/j.jhazmat.2022.12919910.1016/j.jhazmat.2022.129199 ↗
4. 10.1002/adma.20190288510.1002/adma.201902885 ↗
5. 10.1021/acscentsci.1c0086610.1021/acscentsci.1c00866 ↗
6. 10.1016/j.biomaterials.2022.12170410.1016/j.biomaterials.2022.121704 ↗
7. 10.1021/acs.nanolett.2c0254010.1021/acs.nanolett.2c02540 ↗
8. 10.1073/pnas.212311111910.1073/pnas.2123111119 ↗
9. 10.1002/adma.20210650010.1002/adma.202106500 ↗
10. 10.1002/anie.20200788610.1002/anie.202007886 ↗
11. 10.1021/acsnano.6b0541910.1021/acsnano.6b05419 ↗
12. 10.1002/anie.20210986310.1002/anie.202109863 ↗
13. 10.1073/pnas.181702111610.1073/pnas.1817021116 ↗
14. 10.1038/s41467-019-12142-410.1038/s41467-019-12142-4 ↗
15. 10.1021/jacs.1c0201610.1021/jacs.1c02016 ↗
16. 10.1016/j.ccr.2022.21490810.1016/j.ccr.2022.214908 ↗
17. 10.1002/anie.20201326510.1002/anie.202013265 ↗
18. 10.1021/acs.nanolett.9b0102710.1021/acs.nanolett.9b01027 ↗
19. 10.1038/s41467-022-33474-810.1038/s41467-022-33474-8 ↗
20. 10.1002/adma.20160575410.1002/adma.201605754 ↗
21. 10.1002/adfm.20170005610.1002/adfm.201700056 ↗
22. 10.1002/adma.20180443710.1002/adma.201804437 ↗
23. 10.1016/j.scib.2022.05.00110.1016/j.scib.2022.05.001 ↗
24. 10.1002/anie.20190564310.1002/anie.201905643 ↗
25. 10.1016/j.biomaterials.2016.04.03410.1016/j.biomaterials.2016.04.034 ↗
26. 10.1002/anie.20230702010.1002/anie.202307020 ↗
27. 10.1021/jacs.7b0454710.1021/jacs.7b04547 ↗
28. 10.1021/jacs.3c0389910.1021/jacs.3c03899 ↗
29. 10.1021/acsnano.2c0909310.1021/acsnano.2c09093 ↗
30. 10.1021/acsnano.0c0665610.1021/acsnano.0c06656 ↗
31. 10.1021/jacs.1c0957410.1021/jacs.1c09574 ↗
32. 10.1021/acsnano.2c0498310.1021/acsnano.2c04983 ↗
33. 10.1016/j.biomaterials.2020.12040410.1016/j.biomaterials.2020.120404 ↗
34. 10.34133/research.018610.34133/research.0186 ↗
35. 10.1021/acsnano.8b0529210.1021/acsnano.8b05292 ↗
36. 10.1021/acsnano.3c0195510.1021/acsnano.3c01955 ↗
37. 10.1038/s41467-017-01050-010.1038/s41467-017-01050-0 ↗
38. 10.1038/s41467-023-40085-410.1038/s41467-023-40085-4 ↗
39. 10.1126/sciadv.adf332910.1126/sciadv.adf3329 ↗
40. 10.1039/D2CS00613H10.1039/D2CS00613H ↗
41. 10.1038/s41467-019-11728-210.1038/s41467-019-11728-2 ↗
42. 10.1088/1742-6596/1679/2/02204910.1088/1742-6596/1679/2/022049 ↗